Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2023

Open Access 01-12-2023 | giant cell tumor | Research

Complications and prognosis of primary thoracic and lumbar giant cell tumors treated by total tumor resection

Authors: Jiacheng Liu, Panpan Hu, Hua Zhou, Ben Wang, Xiaoguang Liu, Fengliang Wu, Yan Li, Xiao Liu, Lei Dang, Yanchao Tang, Zihe Li, Zhongjun Liu, Feng Wei

Published in: BMC Musculoskeletal Disorders | Issue 1/2023

Login to get access

Abstract

Background

Spinal giant cell tumor (SGCT) is a relatively rare primary tumor. En bloc resection is the preferred surgical procedure for it due to its aggressiveness, meanwhile leading to more complications. We reported the characteristics of perioperative complications and local control of total tumor resection including en bloc resection and piecemeal resection for primary thoracic and lumbar spinal giant cell tumors in a single center over 10 years.

Methods

This is a retrospective cross-sectional and cohort study. Forty-one consecutive patients with SGCTs who underwent total tumor resection from 2010 to 2020 at our institution and were followed up for at least 24 months were reviewed. Surgery data, complication characteristics and local tumor control were collected and compared by different surgical procedure.

Results

Forty-one patients were included, consisting of 18 males and 23 females, with a mean age of 34.2 years. Thirty-one had thoracic vertebra lesions, and 10 had lumbar vertebra lesions. Thirty-five patients were primary cases, and 6 patients were recurrent cases. Eighteen patients were treated by total en bloc spondylectomy (TES), 12 patients underwent en bloc resection according to WBB surgical system, and 11 patients underwent piecemeal resection. The average surgical time was 498 min, and the mean estimated blood loss was 2145 ml. A total of 58 complications were recorded, and 30 patients (73.2%) had at least one perioperative complication. All patients were followed up after surgery for at least 2 years. A total of 6 cases had postoperative internal fixation failure, and 4 cases presented local tumor recurrence (9.8%).

Conclusions

Although the surgical technique is difficult and accompanied by a high rate of perioperative complications, en bloc resection can achieve favorable local control in SGCT. When it is too difficult to complete en bloc resection, thoroughly piecemeal resection without residual is also acceptable, given the relatively low recurrence rate.
Literature
1.
go back to reference Patel S, et al. Incidence, management, and outcomes of spinal giant cell tumor of bone in adult patients: a National Cancer Database Analysis. World Neurosurg. 2020;144:e296–e305.CrossRefPubMed Patel S, et al. Incidence, management, and outcomes of spinal giant cell tumor of bone in adult patients: a National Cancer Database Analysis. World Neurosurg. 2020;144:e296–e305.CrossRefPubMed
2.
go back to reference Boriani S, et al. Giant cell tumor of the mobile spine: a review of 49 cases. Spine (Phila Pa 1976). 2012;37(1):E37–45.CrossRefPubMed Boriani S, et al. Giant cell tumor of the mobile spine: a review of 49 cases. Spine (Phila Pa 1976). 2012;37(1):E37–45.CrossRefPubMed
5.
go back to reference Biermann JS, et al. Guidelines insights: Bone Cancer, Version 2.2017. J Natl Compr Canc Netw. 2017;15(2):155–67.CrossRefPubMed Biermann JS, et al. Guidelines insights: Bone Cancer, Version 2.2017. J Natl Compr Canc Netw. 2017;15(2):155–67.CrossRefPubMed
7.
go back to reference Paholpak P, et al. Total en bloc spondylectomy is worth doing in complete paralysis spinal giant cell tumor, a minimum 1-year follow-up. J Orthop Surg (Hong Kong). 2021;29(1):23094990211005900.CrossRefPubMed Paholpak P, et al. Total en bloc spondylectomy is worth doing in complete paralysis spinal giant cell tumor, a minimum 1-year follow-up. J Orthop Surg (Hong Kong). 2021;29(1):23094990211005900.CrossRefPubMed
8.
go back to reference Kawahara N et al. Total en bloc spondylectomy for spinal tumors: surgical techniques and related basic background. Orthop Clin North Am, 2009. 40(1): p. 47–63, vi. Kawahara N et al. Total en bloc spondylectomy for spinal tumors: surgical techniques and related basic background. Orthop Clin North Am, 2009. 40(1): p. 47–63, vi.
9.
go back to reference Tomita K, et al. Total en bloc spondylectomy for solitary spinal metastases. Int Orthop. 1994;18(5):291–8.CrossRefPubMed Tomita K, et al. Total en bloc spondylectomy for solitary spinal metastases. Int Orthop. 1994;18(5):291–8.CrossRefPubMed
11.
go back to reference Boriani S, Weinstein JN, Biagini R. Primary bone tumors of the spine. Terminology and surgical staging. Spine (Phila Pa 1976). 1997;22(9):1036–44.CrossRefPubMed Boriani S, Weinstein JN, Biagini R. Primary bone tumors of the spine. Terminology and surgical staging. Spine (Phila Pa 1976). 1997;22(9):1036–44.CrossRefPubMed
12.
go back to reference Bandiera S, et al. Complications and risk factors in En Bloc Resection of spinal tumors: a retrospective analysis on 298 patients treated in a single Institution. Curr Oncol. 2022;29(10):7842–57.CrossRefPubMedPubMedCentral Bandiera S, et al. Complications and risk factors in En Bloc Resection of spinal tumors: a retrospective analysis on 298 patients treated in a single Institution. Curr Oncol. 2022;29(10):7842–57.CrossRefPubMedPubMedCentral
13.
go back to reference Boriani S, et al. Predictors for surgical complications of en bloc resections in the spine: review of 220 cases treated by the same team. Eur Spine J. 2016;25(12):3932–41.CrossRefPubMed Boriani S, et al. Predictors for surgical complications of en bloc resections in the spine: review of 220 cases treated by the same team. Eur Spine J. 2016;25(12):3932–41.CrossRefPubMed
14.
go back to reference Demura S, et al. Perioperative complications of total en bloc spondylectomy for spinal tumours. Bone Joint J. 2021;103–B(5):976–83.CrossRefPubMed Demura S, et al. Perioperative complications of total en bloc spondylectomy for spinal tumours. Bone Joint J. 2021;103–B(5):976–83.CrossRefPubMed
15.
go back to reference Matsumoto M, et al. Major Complications and Sequelae after Total En Bloc Spondylectomy for malignant spinal tumors. Neurosurg Q. 2015;25(4):442–51.CrossRef Matsumoto M, et al. Major Complications and Sequelae after Total En Bloc Spondylectomy for malignant spinal tumors. Neurosurg Q. 2015;25(4):442–51.CrossRef
16.
go back to reference Shah AA, et al. Modified En Bloc Spondylectomy for Tumors of the thoracic and lumbar spine: Surgical technique and outcomes. J Bone Joint Surg Am. 2017;99(17):1476–84.CrossRefPubMed Shah AA, et al. Modified En Bloc Spondylectomy for Tumors of the thoracic and lumbar spine: Surgical technique and outcomes. J Bone Joint Surg Am. 2017;99(17):1476–84.CrossRefPubMed
17.
go back to reference Shimizu T, et al. Total en bloc spondylectomy for primary tumors of the lumbar spine. Med (Baltim). 2018;97(37):e12366.CrossRef Shimizu T, et al. Total en bloc spondylectomy for primary tumors of the lumbar spine. Med (Baltim). 2018;97(37):e12366.CrossRef
18.
go back to reference McDonnell MF, et al. Perioperative complications of anterior procedures on the spine. J Bone Joint Surg Am. 1996;78(6):839–47.CrossRefPubMed McDonnell MF, et al. Perioperative complications of anterior procedures on the spine. J Bone Joint Surg Am. 1996;78(6):839–47.CrossRefPubMed
19.
go back to reference Yonezawa N, et al. Giant cell tumor of the thoracic spine completely removed by total spondylectomy after neoadjuvant denosumab therapy. Eur Spine J. 2017;26(Suppl 1):236–42.CrossRefPubMed Yonezawa N, et al. Giant cell tumor of the thoracic spine completely removed by total spondylectomy after neoadjuvant denosumab therapy. Eur Spine J. 2017;26(Suppl 1):236–42.CrossRefPubMed
21.
go back to reference Gouin F, et al. Adjuvant treatment with zoledronic acid after extensive curettage for giant cell tumours of bone. Eur J Cancer. 2014;50(14):2425–31.CrossRefPubMed Gouin F, et al. Adjuvant treatment with zoledronic acid after extensive curettage for giant cell tumours of bone. Eur J Cancer. 2014;50(14):2425–31.CrossRefPubMed
22.
go back to reference Rutkowski P, et al. Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - multicenter analysis outside clinical trial. Eur J Surg Oncol. 2018;44(9):1384–90.CrossRefPubMed Rutkowski P, et al. Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - multicenter analysis outside clinical trial. Eur J Surg Oncol. 2018;44(9):1384–90.CrossRefPubMed
23.
go back to reference Singh AS, Chawla NS, Chawla SP. Giant-cell tumor of bone: treatment options and role of denosumab. Biologics. 2015;9:69–74.PubMedPubMedCentral Singh AS, Chawla NS, Chawla SP. Giant-cell tumor of bone: treatment options and role of denosumab. Biologics. 2015;9:69–74.PubMedPubMedCentral
24.
go back to reference Tse LF, et al. Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case-control study. Bone. 2008;42(1):68–73.CrossRefPubMed Tse LF, et al. Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case-control study. Bone. 2008;42(1):68–73.CrossRefPubMed
25.
go back to reference Xu W, et al. Factors affecting prognosis of patients with giant cell tumors of the mobile spine: retrospective analysis of 102 patients in a single center. Ann Surg Oncol. 2013;20(3):804–10.CrossRefPubMed Xu W, et al. Factors affecting prognosis of patients with giant cell tumors of the mobile spine: retrospective analysis of 102 patients in a single center. Ann Surg Oncol. 2013;20(3):804–10.CrossRefPubMed
26.
go back to reference Kawahara N, et al. Total en bloc spondylectomy of the lower lumbar spine: a surgical techniques of combined posterior-anterior approach. Spine (Phila Pa 1976). 2011;36(1):74–82.CrossRefPubMed Kawahara N, et al. Total en bloc spondylectomy of the lower lumbar spine: a surgical techniques of combined posterior-anterior approach. Spine (Phila Pa 1976). 2011;36(1):74–82.CrossRefPubMed
27.
go back to reference Yokogawa N et al. Postoperative Cerebrospinal Fluid Leakage Associated With Total En Bloc Spondylectomy. Orthopedics, 2015. 38(7): p. e561-6. Yokogawa N et al. Postoperative Cerebrospinal Fluid Leakage Associated With Total En Bloc Spondylectomy. Orthopedics, 2015. 38(7): p. e561-6.
28.
go back to reference Luksanapruksa P, et al. Systematic review and Meta-analysis of En Bloc Vertebrectomy compared with Intralesional Resection for Giant Cell Tumors of the Mobile spine. Global Spine J. 2016;6(8):798–803.CrossRefPubMedPubMedCentral Luksanapruksa P, et al. Systematic review and Meta-analysis of En Bloc Vertebrectomy compared with Intralesional Resection for Giant Cell Tumors of the Mobile spine. Global Spine J. 2016;6(8):798–803.CrossRefPubMedPubMedCentral
29.
go back to reference Yin H, et al. Treatment and outcome of primary aggressive giant cell tumor in the spine. Eur Spine J. 2015;24(8):1747–53.CrossRefPubMed Yin H, et al. Treatment and outcome of primary aggressive giant cell tumor in the spine. Eur Spine J. 2015;24(8):1747–53.CrossRefPubMed
30.
go back to reference Yokogawa N, et al. Total spondylectomy for Enneking stage III giant cell tumor of the mobile spine. Eur Spine J. 2018;27(12):3084–91.CrossRefPubMed Yokogawa N, et al. Total spondylectomy for Enneking stage III giant cell tumor of the mobile spine. Eur Spine J. 2018;27(12):3084–91.CrossRefPubMed
31.
go back to reference Charest-Morin R, et al. En Bloc Resection Versus Intralesional surgery in the treatment of Giant Cell Tumor of the spine. Spine (Phila Pa 1976). 2017;42(18):1383–90.CrossRefPubMed Charest-Morin R, et al. En Bloc Resection Versus Intralesional surgery in the treatment of Giant Cell Tumor of the spine. Spine (Phila Pa 1976). 2017;42(18):1383–90.CrossRefPubMed
Metadata
Title
Complications and prognosis of primary thoracic and lumbar giant cell tumors treated by total tumor resection
Authors
Jiacheng Liu
Panpan Hu
Hua Zhou
Ben Wang
Xiaoguang Liu
Fengliang Wu
Yan Li
Xiao Liu
Lei Dang
Yanchao Tang
Zihe Li
Zhongjun Liu
Feng Wei
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2023
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-023-06347-4

Other articles of this Issue 1/2023

BMC Musculoskeletal Disorders 1/2023 Go to the issue